Risk of second primary malignancies associated with radiotherapy in prostate cancer patients: competing risk analysis.

Abstract

Background: The effect of radiotherapy (RT) for second primary malignancies (SPMs) among prostate cancer survivors iscontroversial. Methods: Applying logistic regression, competing risk analysis and propensity score matching method, this study analyzed clinical data from the Surveillance, Epidemiology, and End Results program to compare the risk for SPMs between patients receiving RT and non-RT. Results: In this study, prostate cancer patients treated with RT developed more SPMs in the anus, bladder, rectum, liver, lung and bronchus and lymphoma than non-RT groups. Conclusion: More intensive surveillance should be adopted for these cancers among prostate cancer survivors.